A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Diffuse Large B Cell Lymphoma (DLBCL) · Follicular Lymphoma (FL) · Mantle Cell Lymphoma (MCL) · Marginal Zone Lymphoma (MZL) · Waldenstrom Macroglobulinemia (WM) · Primary Central Nervous System Lymphoma (PCNSL) · Secondary Central Nervous System Lymphoma (SCNSL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope, Duarte, California, United States

  • University of California, San Francisco, San Francisco, California, United States

    Study coordinator · HDFCCCClinicalTrials@ucsf.edu
  • Colorado Blood Cancer Institute, Denver, Colorado, United States

  • Yale Cancer Center, New Haven, Connecticut, United States

  • University of Miami, Miami, Florida, United States

  • Florida Cancer Specialists, Sarasota, Florida, United States

  • Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

  • Northwestern University, Chicago, Illinois, United States

  • National Institute of Health, Bethesda, Maryland, United States

  • Cayuga Medical Center, Ithaca, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • Duke University Medical Center, Durham, North Carolina, United States

  • University of Cincinnati Medical Center, Cincinnati, Ohio, United States

  • Cleveland Clinic, Cleveland, Ohio, United States

  • University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Ana Ayala) · abayala@mdanderson.org · 713-792-4254
  • Huntsman Cancer Institute, Salt Lake City, Utah, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

  • CHU Angers, Angers, France

  • Hôpital Avicenne, Bobigny, France

  • CHU de Nantes, Nantes, France

  • CHU Bordeaux, Pessac, France

  • CHU de Poitiers, Poitiers, France

  • Institut Curie-Site Saint-Cloud, Saint-Cloud, France

  • CHRU de Nancy, Vandœuvre-lès-Nancy, France

  • IRCCS - AOU di Bologna, Bologna, Italy

  • ASST Spedali Civili Brescia, Brescia, Italy

  • IRCCS Ospedale San Raffaele - Università Vita-Salute San Raffaele di Milano, Milan, Italy

  • IRCCS Ospedale San Raffaele, Milan, Italy

  • Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

  • University Medical Center Groningen, Groningen, Netherlands

  • Radboud University Medical Center, Nijmegen, Netherlands

  • Erasmus MC, Rotterdam, Netherlands

  • University Medical Center Utrecht, Utrecht, Netherlands

  • AidPort sp. Zo.o, Skórzewo, Greater Poland Voivodeship, Poland

  • Pratia MCM, Krakow, Lesser Poland Voivodeship, Poland

  • University Clinical Hostpital in Wroclaw, Wroclaw, Lower Silesian Voivodeship, Poland

  • Pratia MTZ, Warsaw, Masovian Voivodeship, Poland

  • National Institute of Oncology Warszawa, Warsaw, Masovian Voivodeship, Poland

  • Pratia Onkologia Katowice, Katowice, Silesian Voivodeship, Poland

  • Medical University of Lublin, Lublin, Poland

  • Hospital Universitari Vall d'Hebron, Barcelona, Spain

  • Hospital Clínic de Barcelona, Barcelona, Spain

  • Hospital Universitario de Cabuenes, Gijón, Spain

  • Hospital Ramón y Cajal, Madrid, Spain

  • Hospital Fundación Jimenez Díaz - START Madrid, Madrid, Spain

  • Universitätsspital Basel, Basel, Switzerland

  • Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland

  • Inselspital - Universitatsklinik Bern, Bern, Switzerland

  • Hôpitaux Universitaires de Genève, Geneva, Switzerland

  • Kantonsspital St.Gallen, Sankt Gallen, Switzerland

  • University Hospital Zurich, Zurich, Switzerland

  • The Christie NHS Foundation Trust, Manchester, Manchester, United Kingdom

  • The Beatson WOS Cancer Center, Glasgow, Scotland, United Kingdom

  • St. James Hospital, Leeds, United Kingdom

  • Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom

  • St. Bartholomew's Hospital, Barts NHS Trust, London, United Kingdom

  • Sarah Cannon Research Institute UK, London, United Kingdom

  • Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom

  • University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Study leads
  • Study Director

    Nurix Therapeutics, Inc.